Evidence map›Paper›PMID 42741620›Full record

ArticleERJ open research2026

Budesonide/formoterol fumarate dihydrate

Alberto Papi, Robert A Wise, David J Jackson, Njira Lugogo, Ruchong Chen, Hassan Chami, Clara Armengol, Sami Z Daoud, Emma Nauclér, Karin Bowen and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alberto PapiRespiratory Medicine, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Robert A WiseDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-8353-2349
David J JacksonGuy's Severe Asthma Centre, Guy's Hospital, School of Immunology and Microbial Sciences, King's College London, London, UK.
Njira LugogoDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.
Ruchong ChenState Key Laboratory of Respiratory Disease, Joint International Research Laboratory of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, PR China.ORCID https://orcid.org/0000-0001-5376-8230
Hassan ChamiDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Clara ArmengolRespiratory and Immunology, Clinical Development, Biopharmaceuticals R&D, AstraZeneca, Barcelona, Spain.
Sami Z DaoudRespiratory and Immunology, Clinical Development, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Emma NauclérRespiratory and Immunology, Biometrics, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Karin BowenRespiratory and Immunology, Biometrics, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Ayman MegallyRespiratory and Immunology, Clinical Development, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Olami SobandeRespiratory and Immunology, Clinical Development, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Mehul PatelRespiratory and Immunology, Clinical Development, Biopharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Inhaled corticosteroid (ICS)/long-acting β Methods: Participants (aged 12-80 years; N=374) with inadequately controlled asthma (seven-item Asthma Control Questionnaire score ≥1.5) despite low-dose ICS or ICS/LABA were randomised to 12 weeks of twice-daily BFF 160/10 μg (BFF Results: Least-square mean differences (95% CI) demonstrated that BFF Conclusion: These findings support the use of BFF

Identifiers

PMID42741620
PMCPMC13573226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.